Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 155
Filter
1.
J Sci Food Agric ; 103(3): 1342-1354, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36151767

ABSTRACT

BACKGROUND: The aim of this study was to investigate the effects of different doses of chicken spleen transfer factor (TF) on the structure of intestinal epithelial cells in different age groups. One-day-old White Leghorns laying hens were randomly divided into four groups: three groups were administered TF at different dosages (0.10, 0.25 or 1.00 mL) and a fourth group was set as control (administered saline, 1.00 mL). Using hematoxylin and eosin staining, high-throughput sequencing, microbiota analysis, quantitative polymerase reaction and western blotting. RESULTS: We measured the effects of different doses of TF on the following: intestinal mucosal epithelial tissue morphology, intestinal mucosal epithelial barrier-related gene expression profiles, and intestinal epithelial tight junction gene protein levels. The collected data show that TF can improve the absorption of nutrients by increasing villus height and crypt depth, and regulate intestinal flora disorders. Furthermore, we verified that the expression of the claudin and occludin tight junctions between intestinal epithelial cells was increased with TF. this research is very important for focusing on the structure and gene expression of intestinal tissues. CONCLUSION: The results provide a scientific rationale for feeding and nutrition programs for green and healthy farming, as well as technical support to improve the production efficiency of the livestock and poultry breeding industry. © 2022 Society of Chemical Industry.


Subject(s)
Chickens , Transfer Factor , Animals , Female , Transfer Factor/metabolism , Transfer Factor/pharmacology , Chickens/genetics , Spleen , Intestinal Mucosa/metabolism , Epithelial Cells/metabolism
2.
Chemosphere ; 308(Pt 3): 136590, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36167200

ABSTRACT

Although the single role of selenium (Se) or phosphorus (P) in regulating the As contamination of rice plants has been reported in some studies, the combined impacts of Se and P on the fate of As and the underlying mechanisms are poorly understood. To address this knowledge gap, the uptake, translocation, and biotransformation of As mediated by Se were investigated in rice (Oryza sativa L.) seedlings hydroponically cultured with P-normal and P-deficient conditions. The results showed Se addition stimulated the uptake of arsenite and arsenate by 15.6% and 30.7%, respectively in P-normal condition, and such effect was more profound in P-deficient condition with the value of 43.8% and 70.8%. However, regardless of Se addition, P-deficiency elevated the As uptake by 47.0%-92.1% for arsenate but had no obvious effects for arsenite. Accompanying with the As transfer factorShoot/Root reduced by 74.5%-80.2% and 71.1%-85.7%, Se addition decreased the shoot As content by 65.8%-69.7% and 59.6%-73.1%, respectively, in the arsenite- and arsenate-treated rice plants. Relative to the corresponding treatments of P-normal condition, P-deficiency reduced the As transfer factorShoot/Root by 38.9%-52.5% and thus decreasing the shoot As content by 35.2%-42.5% in the arsenite-treated plants; while the opposite impacts were observed in the arsenate-treated plants, in which the shoot As content was increased by 22.4%-83.7%. The analysis results of As species showed As(III) was dominant in both shoots (68.9%-75.1%) and roots (94.9%-97.2%), and neither Se addition nor P-deficiency had obvious impacts on the interconversion between As(III) and As(V). Our results demonstrate the regulating roles of Se in As accumulation mainly depend on P regimes and the specific rice tissues, but the effects of P-deficiency on the fate of As were influenced by the form of As added to the culture.


Subject(s)
Arsenic , Arsenites , Oryza , Selenium , Arsenates/metabolism , Arsenates/toxicity , Arsenic/metabolism , Arsenites/metabolism , Oryza/metabolism , Phosphorus/metabolism , Phosphorus/pharmacology , Plant Roots/metabolism , Seedlings , Selenium/metabolism , Selenium/pharmacology , Transfer Factor/metabolism , Transfer Factor/pharmacology
3.
Chemosphere ; 307(Pt 1): 135754, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35863419

ABSTRACT

Remediation of the cesium-contaminated environment is of paramount importance, and phytoremediation is a cost-effective and green technique. In this paper, the response of Amaranthus tricolor to cesium ions in hydroponic solution was investigated at various cesium concentration (0, 0.05, 0.2, 0.4 and 0.6 mM), in terms of the growth weight, height and photosynthesis. The maximal Cs content in stems and leaves of A. tricolor was 13.05 mg/g dry wt under spiked Cs level of 0.4 mM in solution. The maximal transfer factor (TF) and bioconcentration factor (BCF) were 1.87 and 181.25 respectively, when the corresponding Cs content in roots and shoots was 7.04 mg/g and 13.05 mg/g dry wt respectively. TFs are higher than 1 in the conditions of normal plant growth. The growth of A. tricolor was enhanced after the treatment of Cs at low concentrations (0.05 and 0.2 mM), while it was inhibited at 0.4 and 0.6 mM. The leaf number and dry weight of stem, leaf parts and root parts were maximum at the spiked cesium level of 0.2 mM, which significantly increased by 19.19%, 47.56% and 94.56% respectively, compared with the control samples. Under 0.6 mM cesium stress, curl and withering of the leaves occurred, and the plant growth and cesium accumulation dropped to the minimum. Cs at the spiked level of 0.6 mM in solution inhibited the performance of PSII, especially in terms of blockage in electron transfer process beyond QA and restraint of P700 reduction. On contrast, the performance of PSII was enhanced by the spiked Cs at level of 0.2 mM, leading to the growing density of reaction centers per excited cross-section and increasing electron transfer process beyond QA. In summary, A. tricolor has potential for remediating the Cs-contaminated environment.


Subject(s)
Amaranthus , Cesium/pharmacology , Hydroponics , Photosynthesis , Transfer Factor/pharmacology
4.
Ecotoxicol Environ Saf ; 240: 113683, 2022 Jul 15.
Article in English | MEDLINE | ID: mdl-35653975

ABSTRACT

In order to identify the key transport process that determines the Cd concentration in brown rice, this study used 21 hybrid rice varieties as experimental materials and conducted field experiments in Qiyang (cadmium-contaminated site) and Yongding (low-cadmium site). Cd concentrations in 8 organs were measured, and bioconcentration factors and transfer factor were further calculated. The results showed that the Cd concentrations of the organs related to the xylem transport were as follows: root > node > stem > leaf sheath > leaf. In the phloem, the Cd concentrations were as follows: rachis > brown rice > rice husk. And the results of the correlation analysis found that Cd concentration between brown rice and root showed a significant positive correlation in Cd-contaminated site, but no significant correlation in low-cadmium site. Meanwhile, at both experimental sites, the Cd concentration of brown rice showed the most significant correlation with the phloem transfer factor from leaf and leaf sheath to brown rice. Principal Component Analysis (PCA) and stepwise regression analysis likewise found that Cd concentration in leaf and leaf sheath and their phloem transport of Cd to brown rice were significantly and positively correlated with Cd concentration in brown rice. The above results showed that the transport of leaf and leaf sheath to brown rice was a key process, and played a more important role in the accumulation of cadmium in brown rice than in root.


Subject(s)
Oryza , Soil Pollutants , Cadmium/analysis , Edible Grain/chemistry , Soil , Soil Pollutants/analysis , Transfer Factor/pharmacology
5.
Br J Cancer ; 124(8): 1398-1410, 2021 04.
Article in English | MEDLINE | ID: mdl-33531687

ABSTRACT

BACKGROUND: Cancer recurrence is a serious problem in breast cancer (BC) patients, and immunogenic cell death (ICD) has been proposed as a strategy to overcome this recurrence. IMMUNEPOTENT CRP (ICRP) acts as an immunomodulator and can be cytotoxic to cancer cells. Thus, we evaluated if ICRP induces ICD in BC cells. METHODS: Immunogenicity of ICRP-induced cell death was evaluated in vitro, analysing the principal biochemical characteristics of ICD in MCF-7, MDA-MB-231 and 4T1 cells. Ex vivo, we assessed the ability of killed cancer cells (KCC) obtained from ICRP-treated 4T1 cells (ICRP-KCC) to induce DC maturation, T-cell priming and T-cell-mediated cancer cytotoxicity. In vivo, we evaluated tumour establishment and antitumour immune memory after prophylactic ICRP-KCC vaccination in BALB/c mice. RESULTS: ICRP induced caspase-independent, ROS-dependent cell death, autophagosome formation, P-eIF2α, chaperone protein exposure, CD47 loss, ATP and HMBG1 release in BC cells. Additionally, ICRP-KCC promoted DC maturation, which triggered T-cell priming and cancer cytotoxicity. Prophylactic vaccination with ICRP-KCC prevented tumour establishment and induced long-term antitumour memory in BALB/c mice, involving DC maturation in lymph nodes, CD8+ T-cell augmentation in lymph nodes, peripheral blood and tumour site and ex vivo tumour-specific cytotoxicity by splenocytes. CONCLUSIONS: ICRP induces ICD in BC cells, leading to long-term antitumour memory.


Subject(s)
Breast Neoplasms/prevention & control , CD8-Positive T-Lymphocytes/metabolism , Dendritic Cells/metabolism , Neoplasm Recurrence, Local/prevention & control , Transfer Factor/administration & dosage , Animals , Breast Neoplasms/immunology , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Female , Humans , Immunogenic Cell Death , MCF-7 Cells , Mice , Mice, Inbred BALB C , Neoplasm Recurrence, Local/immunology , Transfer Factor/pharmacology , Vaccination , Xenograft Model Antitumor Assays
6.
J Immunol Res ; 2019: 2198508, 2019.
Article in English | MEDLINE | ID: mdl-31093509

ABSTRACT

Transferon® is a complex drug based on a mixture of low molecular weight peptides. This biotherapeutic is employed as a coadjuvant in clinical trials of several diseases, including viral infections and allergies. Given that macrophages play key roles in pathogen recognition, phagocytosis, processing, and antigen presentation, we evaluated the effect of Transferon® on phenotype and function of macrophage-like cells derived from THP-1 monocytes. We determined the surface expression of CD80 and CD86 by flow cytometry and IL-1ß, TNF-α, and IL-6 levels by ELISA. Transferon® alone did not alter the steady state of PMA-differentiated macrophage-like THP-1 cells. On the contrary, simultaneous stimulation of cells with Transferon® and LPS elicited a significant increase in CD80 (P ≤ 0.001) and CD86 (P ≤ 0.001) expression, as well as in IL-6 production (P ≤ 0.05) compared to the LPS control. CD80 expression and IL-6 production exhibited a positive correlation (r = 0.6, P ≤ 0.05) in cells exposed to Transferon® and LPS. Our results suggest that the administration of Transferon® induces the expression of costimulatory molecules and the secretion of cytokines in LPS-activated macrophages. Further studies are necessary to determine the implication of these findings in the therapeutic properties of Transferon®.


Subject(s)
B7-1 Antigen/genetics , Interleukin-6/immunology , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Macrophages/immunology , Transfer Factor/pharmacology , B7-1 Antigen/immunology , B7-2 Antigen/genetics , B7-2 Antigen/immunology , Cell Differentiation/drug effects , Cytokines/immunology , Flow Cytometry , Humans , Leukocyte Count , Monocytes/drug effects , THP-1 Cells
7.
Biomed Pharmacother ; 101: 938-944, 2018 May.
Article in English | MEDLINE | ID: mdl-29635903

ABSTRACT

Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide. Dialyzed Leukocyte Extracts (DLEs) are heterogeneous mixtures of low-molecular-weight peptides that improve clinical responses in various diseases. Here, we analyzed the effects of TransferonTM, a commercial DLE with characterized active pharmaceutical ingredient and proven batch-to-batch reproducibility, in preclinical models of PCa. We employed v-Src-transformed murine prostate epithelial (PEC-Src) cells, which recapitulate the transcriptional profiles in human PCa, can be grown in immunocompetent mice, and consistently form bone and brain metastases. In vitro, TransferonTM did not induce cytotoxicity nor alterations in migration /invasion of PEC-Src cells. In vivo, TransferonTM reduced metastatic dissemination after intracardiac injection of PEC-Src and inhibited tumor growth of subcutaneous isotransplants. The antineoplastic effect of TransferonTM correlated with changes in tumor infiltration, increased serum concentrations of IL-12 and CXCL1, and reduced levels of VEGF. Our results suggest that the antineoplastic effect produced by TransferonTM is due to its immunomodulatory activity and not by a direct effect on cancer cells, and indicate that TransferonTM could be beneficial as adjuvant therapy in PCa patients.


Subject(s)
Brain Neoplasms/secondary , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/pathology , Transfer Factor/therapeutic use , Animals , Antineoplastic Agents/pharmacology , Cell Death/drug effects , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Disease Models, Animal , Interleukin-1/metabolism , Interleukin-12/metabolism , Male , Mice , Neoplasm Invasiveness , Transfer Factor/pharmacology , Vascular Endothelial Growth Factor A/metabolism
8.
Drug Dev Res ; 78(5): 189-195, 2017 08.
Article in English | MEDLINE | ID: mdl-28639277

ABSTRACT

Preclinical Research Transfer Factors (TFs) are low molecular weight (<5,000 daltons) biological response mediators. In the present study, a serum derived TF improved the ability of the recipient animal to survive high-risk infectious challenges (salmonellosis and canine parvoviral enteritis (CPV)) by altering the host's cytokine response profile. Mice mortally challenged with 5,000 colony-forming units of Salmonella experienced a group mortality of 73% while mice treated with a single 5 mg dose of the TF demonstrated a significant decrease in morbidity (7%, p ≤ 0.01). The splenic bacterial load in untreated mice was over 10,000 times higher than that in the TF treated mice. Twenty-four hours post-administration, the treated murine population expressed a rapid temporal increase in serum IL-6 (26-fold) and INF-γ (77-fold) concentrations. IL-6 can act as a critical signal regulating action against bacterial pathogens. A comparative double-blind study performed using dogs confirmed to be undergoing a canine parvovirus challenge showed that when conventional supportive therapy was supplemented with a single 5 mg TF dose there was a reduction (p ≤ 0.01) in group mortality (68% of the TF treated group survived versus 32% of the placebo group), an observation consistent with the observed increase in INF-γ, a cytokine associated with promoting antiviral activity. Drug Dev Res 78 : 189-195, 2017. © 2017 Wiley Periodicals, Inc.


Subject(s)
Dog Diseases/drug therapy , Parvoviridae Infections/drug therapy , Parvovirus, Canine/pathogenicity , Salmonella Infections, Animal/drug therapy , Salmonella typhimurium/pathogenicity , Transfer Factor/administration & dosage , Animals , Bacterial Load/drug effects , Cell Line , Cytokines/metabolism , Disease Models, Animal , Dog Diseases/immunology , Dog Diseases/virology , Dogs , Double-Blind Method , Female , Immunity, Innate/drug effects , Male , Mice , Parvoviridae Infections/veterinary , Parvoviridae Infections/virology , Parvovirus, Canine/drug effects , Parvovirus, Canine/immunology , Random Allocation , Salmonella Infections, Animal/immunology , Salmonella Infections, Animal/microbiology , Salmonella typhimurium/drug effects , Salmonella typhimurium/immunology , Survival Analysis , Transfer Factor/blood , Transfer Factor/pharmacology
9.
J Pharm Biomed Anal ; 138: 100-108, 2017 May 10.
Article in English | MEDLINE | ID: mdl-28189890

ABSTRACT

The human Dialyzed Leukocyte Extract (DLE) is a heterogeneous mix of oligopeptides of <10kDa, extracted from leukocytes of healthy donors. There is significant clinical evidence of improvement using DLE during treatment of allergies, cancer,immunodeficiencies, and in mycotic and viral infections. Nevertheless, the DLE exact nature and mechanism of action have been elusive for more than 50 years. DLE biological activity testing is necessary in DLE production and quality control. Both in vitro and in vivo assays exist: E-rosette test, induction of delayed type hypersensitivity in mice, leukocyte migration and IFN-γ secretion. The animal-origin materials and in vivo assays convey a considerable logistic, ethic and economic burden, meanwhile the available in vitro assays have been reported with limited reproducibility and sometimes contradictory results. Here we are reporting a new DLE biological activity cell-based assay. The A20 and Jurkat cell lines were treated with (+Aza) or without (-Aza) azathioprine, DLE (+DLE) or both (+Aza/+DLE). After 72h, the cell proliferation was analyzed by the MTT or BrdU incorporation assays. In +Aza/+DLE treated cells, we observed a significant higher proliferation, when compared with +Aza/-DLE. In the absence of Aza, cells did not present any proliferation difference between -DLE or +DLE treatments. Both assays, MTT and BrdU showed similar results, being the MTT test more cost effective and we select it for validation as DLE biological assay using Jurkat cells only. We tested three different lyophilized DLE batches and we found consistent results with acceptable assay reproducibility and linearity. The DLE capacity for rescuing Jurkat cell proliferation during +Aza treatment was consistent using different liquid and lyophilized DLE batches, presenting also consistent chromatographic profiles. Finally, DLE treatment in Jurkat cells did not result into significant IL-2 of IFN-γ secretion, and known lymphocyte proliferative drugs failed to rescue Jurkat cells viability in presence of +Aza, as +DLE treatment did in our MTT assay. In conclusion, our new cell-based MTT assay has excellent DLE biological activity consistency, robustness and is cost effective, presenting important advantages over previous DLE activity in vitro and in vivo assays.


Subject(s)
Azathioprine/pharmacology , Cell Proliferation/drug effects , Jurkat Cells/drug effects , Jurkat Cells/physiology , Leukocytes/drug effects , Leukocytes/physiology , Transfer Factor/pharmacology , Animals , Cell Line, Tumor , Cost-Benefit Analysis/methods , Humans , Mice , Reproducibility of Results
10.
J Immunol Res ; 2016: 4097642, 2016.
Article in English | MEDLINE | ID: mdl-27847830

ABSTRACT

Reconstitution of the hematopoietic system during immune responses and immunological and neoplastic diseases or upon transplantation depends on the emergent differentiation of hematopoietic stem/progenitor cells within the bone marrow. Although in the last decade the use of dialyzable leukocyte extracts (DLE) as supportive therapy in both infectious and malignant settings has increased, its activity on the earliest stages of human hematopoietic development remains poorly understood. Here, we have examined the ability of DLE to promote replenishment of functional lymphoid lineages from CD34+ cells. Our findings suggest that DLE increases their differentiation toward a conspicuous CD56+CD16+CD11c+ NK-like cell population endowed with properties such as IFNy production, tumor cell cytotoxicity, and the capability of inducing γδ T lymphocyte proliferation. Of note, long-term coculture controlled systems showed the bystander effect of DLE-stromal cells by providing NK progenitors with signals to overproduce this cell subset. Thus, by direct effect on progenitor cells and through activation and remodeling of the supporting hematopoietic microenvironment, DLE may contribute a robust innate immune response by promoting the emerging lymphopoiesis of functional CD11c+ NK cells in a partially TLR-related manner. Unraveling the identity and mechanisms of the involved DLE components may be fundamental to advance the NK cell-based therapy field.


Subject(s)
Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Lymphocyte Activation , Lymphopoiesis , T-Lymphocyte Subsets/immunology , Transfer Factor/pharmacology , CD11c Antigen/analysis , Cells, Cultured , Coculture Techniques , Hematopoietic Stem Cells/physiology , Humans , Immunophenotyping , Interferon-gamma/biosynthesis , Killer Cells, Natural/physiology , Receptors, Antigen, T-Cell, gamma-delta , Stromal Cells/physiology , T-Lymphocyte Subsets/physiology
11.
Scand J Rheumatol ; 45(6): 528-535, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27098310

ABSTRACT

OBJECTIVES: To evaluate the effect of dialysable leucocyte extract (DLE) on pro- and anti-inflammatory profiles in a rat model of osteoarthritis (OA). METHOD: Forty-eight male Wistar rats were divided into three groups: normal rats without treatment, OA rats treated with placebo, and OA rats treated with DLE. After treatment, the animals were killed to obtain cartilage for histological analysis and to determine the expression of pro- and anti-inflammatory cytokines by reverse transcription multiplex polymerase chain reaction (RT-MPCR) and immunohistofluorescence analyses. RESULTS: Histological analysis revealed that OA cartilage from rats treated with DLE displayed similar characteristics to non-OA cartilage from the control group. The OA cartilage treated with placebo showed alterations in the cellular architecture and in chondrocyte cluster formation. Analysis of cytokine expression by RT-MPCR showed that OA cartilage from DLE-treated rats expressed platelet-derived growth factor (PDGF), interferon (IFN)-γ, and fibroblast growth factor (FGF)-2, similar to non-OA cartilage from the control group. However, OA cartilage from rats treated with placebo expressed interleukin (IL)-1, PDGF, and I kappa B (IκB). Confocal immunodetection of FGF-2, PDGF, and non-phosphorylated IκB showed that they were distributed in the cytoplasm of most chondrocytes in OA cartilage from DLE-treated rats whereas no nuclear factor kappa B (NF-κB) expression was observed in the nuclei. Instead, in OA cartilage from the placebo group, only weak FGF-2 staining was observed, PDGF and IκB were not detected, and NF-κB was strongly observed in both cytoplasm and nuclei. CONCLUSIONS: Our findings suggest that DLE treatment modifies the OA process, promoting the expression of anti-inflammatory cytokines and diminishing the inflammatory effects, avoiding the nuclear translocation of NF-κB in chondrocytes.


Subject(s)
Arthritis, Experimental/drug therapy , Osteoarthritis/drug therapy , Transfer Factor/therapeutic use , Animals , Arthritis, Experimental/metabolism , Arthritis, Experimental/pathology , Chondrocytes/drug effects , Chondrocytes/metabolism , Cytokines/metabolism , Drug Evaluation, Preclinical , Fibroblast Growth Factor 2/metabolism , I-kappa B Proteins/metabolism , Male , NF-kappa B/metabolism , Osteoarthritis/metabolism , Osteoarthritis/pathology , Platelet-Derived Growth Factor/metabolism , Rats, Wistar , Transfer Factor/pharmacology
12.
Folia Biol (Praha) ; 60(6): 253-60, 2014.
Article in English | MEDLINE | ID: mdl-25629265

ABSTRACT

A low-molecular-weight (under 10 kDa) dialysable leukocyte extract (called transfer factor, TF) has been shown to be a prospective substance to improve or modulate immune response in autoimmunity, inflammation, infectious diseases or cancers. However, the use of TF has been limited by the absence of any data on the mechanism of its action. Here we show that TF prepared from peripheral blood leukocytes of healthy human donors displays multiple regulatory effects on individual parameters of the immune system. TF decreases proliferation of T and B lymphocytes and partially alters the production of cytokines and nitric oxide by activated macrophages. TF also inhibits production of T helper 1 (Th1) cytokines interleukin 2 (IL-2) and interferon γ, slightly stimulates production of Th2 cytokine IL-10 and considerably enhances the secretion of IL-17 by activated mouse spleen T cells. At the molecular level, TF enhances expression of genes for transcription factor RORγt and for IL-17. The enhanced expression of the RORgt gene corresponds with an increase in the number of RORγt⁺CD4⁺ Th17 cells and with enhanced IL-17 production. In contrast, the expression of the Foxp3 gene and the proportion of CD4⁺CD25⁺Foxp3⁺ regulatory T cells are not significantly changed in the presence of TF. These results suggest that the activation of pro-inflammatory Th17 cells, which have multiple immunoregulatory properties, could be the main mechanism of the immunomodulatory action of a low-molecular-weight leukocyte extract.


Subject(s)
Adjuvants, Immunologic/pharmacology , CD4-Positive T-Lymphocytes/drug effects , Interleukin-17/biosynthesis , Lymphocyte Subsets/drug effects , Nuclear Receptor Subfamily 1, Group F, Member 3/biosynthesis , Transfer Factor/pharmacology , Animals , B-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/metabolism , Cell Division/drug effects , Cells, Cultured , Concanavalin A/pharmacology , Drug Evaluation, Preclinical , Forkhead Transcription Factors/biosynthesis , Forkhead Transcription Factors/genetics , Gene Expression Regulation/drug effects , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Interleukin-17/genetics , Interleukins/biosynthesis , Interleukins/genetics , Lymphocyte Activation/drug effects , Lymphocyte Subsets/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred BALB C , Molecular Weight , Nitric Oxide/biosynthesis , Nuclear Receptor Subfamily 1, Group F, Member 3/analysis , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Real-Time Polymerase Chain Reaction , Spleen/cytology
13.
Nan Fang Yi Ke Da Xue Xue Bao ; 33(12): 1827-30, 2013 Dec.
Article in Chinese | MEDLINE | ID: mdl-24369255

ABSTRACT

OBJECTIVE: To prepare the oral solution of egg yolk hepatitis B virus (HBV)-specific transfer factor (EYHBV-TF) and evaluate its immunological activity as an immune regulator against hepatitis B. METHODS: From hens immunized with the Hepatitis B vaccine the egg yolk was isolated to extract the specific transfer factor EYHBV-TF, and its physicochemical properties were examined. Leukocyte adhesion inhibition test (LAI) was performed to detect the immunogenic activity of EYHBV-TF. The solution of EYHBV-TF was then administered orally in normal mice, and the specific cellular immune activity induced was assayed with delayed type skin hypersensitivity test (DTH), with the non-specific immune activity assessed with immune organ index. The immune responses induced by oral EYHBV-STF solution were compared with those by EYHBV-STF injection and by different dosages (injection and oral) of porcine spleen HBV-specific transfer factor (PSHBV-STF), porcine spleen nonspecific transfer factor, and egg yolk extracts from non-immunized hens. RESULTS: The prepared EYHBV-STF oral solution, which met the standards for biological products, could inhibit leukocyte adhesion in vitro and significantly enhance mouse foot pad swelling, demonstrating its capability of transferring antigen-specific delayed type hypersensitivity reactions to naive recipient. EYHBV-STF oral solution also significantly improved the immune organ index in mice (P<0 01) with similar effects to those caused by EYHBV-STF injections and by PSHBV-STF injection and oral solution. CONCLUSION: Orally administered EYHBV-STF and EYHBV-STF injection both possess hepatitis B antigen-specific cellular immune activity and can significantly enhance specific cellular immune responses.


Subject(s)
Hepatitis B virus/drug effects , Hepatitis B/drug therapy , Immunity, Cellular , Transfer Factor/pharmacology , Animals , Chickens , Egg Yolk/chemistry , Hepatitis B Antigens , Immunization , Mice , Swine , Transfer Factor/administration & dosage
14.
Vopr Onkol ; 57(1): 81-5, 2011.
Article in Russian | MEDLINE | ID: mdl-21598714

ABSTRACT

The report discusses our experimental data in support of biotherapy which uses chemotherapy and antitumor immune treatment with in vivo xenogenic transfer-factor polypeptides (TFP) isolated from lymphocytes sensitized to antigens of given tumor. After excision of primary tumor--lung carcinoma of Lewis--mice C57BL/6 were injected intraperitoneally with xenogenic TFP (200 pg/body, twice) and a cytostaic dose of cyclophosphamide. Such adjuvant chemotherapy was found to prevent metastases from spreading to the lung in 100%. The marked anti-metastatic effect of the treatment correlated with recovery of splenic cell mass and its cellular structure, higher levels of large granular lymphocytes in peripheral blood and enhanced functional activity of cytotoxic cells in vitro. Our results point to a possibility of raising efficacy of treating solid malignancies with adjuvant chemotherapy in combination with adoptive immune therapy.


Subject(s)
Carcinoma, Lewis Lung/prevention & control , Cyclophosphamide/pharmacology , Immunosuppressive Agents/pharmacology , Immunotherapy, Adoptive/methods , Lung Neoplasms/prevention & control , Transfer Factor/pharmacology , Animals , Antineoplastic Agents, Alkylating/administration & dosage , Antineoplastic Agents, Alkylating/pharmacology , Carcinoma, Lewis Lung/secondary , Cyclophosphamide/administration & dosage , Immunosuppressive Agents/administration & dosage , Injections, Intraperitoneal , Lung Neoplasms/secondary , Mice , Mice, Inbred C57BL , Peptides/pharmacology , Transfer Factor/administration & dosage
15.
Immunopharmacol Immunotoxicol ; 32(4): 637-46, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20205507

ABSTRACT

BACKGROUND: Skin cancers are common, and there has recently been a dramatic increase in their incidence, particularly in the occurrence of melanoma. Furthermore, relapse after curative surgical treatment of melanoma remains a significant clinical challenge and accounts for most of the mortality of this disease. OBJECTIVE: The aim of this study was to determine whether IMMUNEPOTENT CRP affects B16F10 melanoma cells and tumors growth and vascular endothelial growth factor (VEGF) production in vivo and in vitro. METHODS: B16F10 cells and B16F10-inoculated mice were treated with different concentrations of IMMUNEPOTENT CRP. Outcomes were then evaluated using MTT, TUNEL, Caspase-3, senescence, ELISA and colorimetric assays. Parameters related to survival and tumor weight were also assessed. RESULTS: IMMUNEPOTENT CRP decreased the viability of B16F10 cells by increasing apoptosis of the treated cells, and VEGF production was decreased both in vitro and in vivo. Furthermore, treatment prevented metastasis, delayed the appearance of tumors, decreased tumor weight and improved the survival of tumor-bearing mice. DISCUSSION: These observations suggest that IMMUNEPOTENT CRP can be used to suppress growth and metastasis by using targeting proteins such as VEGF.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents/pharmacology , Melanoma, Experimental/prevention & control , Transfer Factor/pharmacology , Transfer Factor/therapeutic use , Angiogenesis Inhibitors/therapeutic use , Animals , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Caspase 3/metabolism , Cattle , Cell Line, Tumor , Cell Survival/drug effects , Cellular Senescence/drug effects , Dose-Response Relationship, Drug , Female , Melanoma, Experimental/metabolism , Melanoma, Experimental/mortality , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , Neoplasm Metastasis/prevention & control , Vascular Endothelial Growth Factor A/blood , Vascular Endothelial Growth Factor A/metabolism
16.
Cytotherapy ; 10(2): 212-9, 2008.
Article in English | MEDLINE | ID: mdl-18368600

ABSTRACT

BACKGROUND: We have previously demonstrated that bovine dialyzable leukocyte extract (bDLE) induces death through an apoptosis mechanism in MCF-7 breast cancer cells. Depending on the cell type and stimulus, activating protein-1 (AP-1) has been shown to regulate cell proliferation and differentiation, the stress response, apoptosis and survival. It remains unknown whether AP-1 and other transcription factors are mechanisms by which bDLE induces cell death. METHODS: To determine whether bDLE modulates the AP-1 DNA binding and gene expression, MCF-7 breast cancer cells were treated with bDLE (0, 1, 5, 10 U) for 72 h and evaluated by electrophoretic mobility shift assay, reverse transcriptase-polymerase chain reaction and Western blot assays. RESULTS: bDLE induced inhibition of cell growth, suppressed the AP-1 DNA-binding activity, decreased c-Jun protein expression and modulated NFATx, NFATc, NFkappaB, c-Jun and c-Fos transcription factor gene expression in MCF-7 breast cancer cells. DISCUSSION: The present data indicate that bDLE can block the AP-1 DNA-binding activity and expression of several transcriptions factors in breast cancer cells, which will have great potential in improving cancer therapy.


Subject(s)
Breast Neoplasms/genetics , Cell Nucleus/drug effects , Cell Nucleus/metabolism , DNA, Neoplasm/metabolism , Transcription Factor AP-1/genetics , Transcription Factor AP-1/metabolism , Transfer Factor/pharmacology , Animals , Breast Neoplasms/pathology , Cattle , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Protein Binding/drug effects , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism
17.
Cytotherapy ; 9(4): 379-85, 2007.
Article in English | MEDLINE | ID: mdl-17573613

ABSTRACT

BACKGROUND: In the current study, we determined whether bovine dialyzable leukocyte extract (bDLE) modulates lipopolysaccharide (LPS)-induced nitric oxide and cytokine overproduction. METHODS: Human whole blood cells were treated with LPS (50 ng) + bDLE (1 U). RESULTS: The bDLE treatment decreased nitric oxide as well as TNF-alpha, IL-6 and IL-10 (P <0.01) cytokine production. In addition, it decreased TNF-alpha, IL-1beta and IL-6 mRNA expression and suppressed IL-10 and IL-12p40 mRNA expression, but did not modulate IL-8 mRNA expression in LPS-stimulated human blood cells. DISCUSSION: Our results suggest that bDLE may effectively modulate the fatal symptoms of hypotensive shock associated with endotoxin (LPS)-induced nitric oxide and cytokine production, and this may offer therapeutic potential for the treatment of endotoxic shock.


Subject(s)
Blood Cells/drug effects , Blood Cells/metabolism , Cytokines/genetics , Cytokines/metabolism , Lipopolysaccharides/pharmacology , Nitric Oxide/biosynthesis , Transfer Factor/pharmacology , Animals , Cattle , Cell Survival/drug effects , Gene Expression Regulation/drug effects , Humans , Inflammation Mediators
18.
Fiziol Zh (1994) ; 53(1): 24-32, 2007.
Article in Ukrainian | MEDLINE | ID: mdl-17500199

ABSTRACT

Transfer factor (TF) of immune reactivity (10(-5) - 10(-3) mg/ml) to diphtheria-tetanus anatoxin modulates slow waves and spontaneous contractile activity of non-atropinized smooth muscle stripes (SMS) of guinea-pig taenia coli. TF (10(-4) mg/ml) transforms slow waves into stable depolarization and tonic contraction. After SMS atropinization, the substance acts in the same way. In the presence of methylene blue (10(-5) M), a guanylatecyclase blocker, FT induces transitory increase of SMS muscle tone, which is followed by their stable relaxation. ATP and UTP, purinoceptors agonists, evoke substantial hyperpolarization of smooth muscle cells membrane and their relaxation. FT enhances post-inhibitory excitation in SMS. In the presence of acetylcholine (10(-5) M) FT (10(-4) mg/ml) transforms the inhibitory ATP action on tonic contraction into excitative. This substance (10(-5), 10(-4) mg/ml) enhances Ca2+ mobilization from ryanodine-sensitive calcium store, inhibits the release of these cations from IP3-sensitive calcium store of sarcoplasmic reticulum. TF demolishes the inhibitory actions of sodium nitroprusside (nitric oxide donor), and noradrenaline in taenia coli smooth muscles.


Subject(s)
Colon , Diphtheria Toxoid/immunology , Muscle Relaxation/drug effects , Muscle, Smooth , Neurotransmitter Agents/pharmacology , Tetanus Toxoid/immunology , Transfer Factor/pharmacology , Animals , Calcium/metabolism , Colon/drug effects , Colon/immunology , Colon/innervation , Electric Stimulation , Guinea Pigs , In Vitro Techniques , Membrane Potentials/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/immunology , Muscle, Smooth/innervation , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/immunology , Transfer Factor/immunology
19.
Clin Exp Pharmacol Physiol ; 34(5-6): 515-6, 2007.
Article in English | MEDLINE | ID: mdl-17439424

ABSTRACT

1. Slow inotropic response following a sudden myocardium stretch seems to be an autocrine/paracrine mechanism the basis of which is not yet completely defined. 2. We compared the canine left ventricle (LV) response to sudden dilation when the LV was supported by the arterial blood of a support dog with when it was supported by an oxygenator + haemodialyser system. 3. A slow inotropic response (SIR) after dilation was seen in all six hearts supported by the donor dog, attaining 87 +/- 6% of immediate increase, whereas a mere 10% SIR occurred in only one out of seven hearts maintained by the oxygenator + haemodialyser. 4. These results indicate that SIR genesis involves one or more renewable components essential to the intracellular calcium gain elicited by stretch.


Subject(s)
Dilatation, Pathologic/physiopathology , Heart/physiopathology , Myocardial Contraction/physiology , Ventricular Function, Left/physiology , Animals , Autocrine Communication/drug effects , Autocrine Communication/physiology , Blood Pressure/drug effects , Dialysis Solutions/chemistry , Dialysis Solutions/pharmacology , Dogs , Glucose/administration & dosage , Glucose/pharmacology , Heart/drug effects , Heart Rate/drug effects , In Vitro Techniques , Male , Myocardial Contraction/drug effects , Oxygenators, Membrane , Paracrine Communication/drug effects , Paracrine Communication/physiology , Perfusion/methods , Renal Dialysis/instrumentation , Renal Dialysis/methods , Transfer Factor/chemistry , Transfer Factor/pharmacology , Tromethamine/administration & dosage , Tromethamine/pharmacology , Ventricular Function, Left/drug effects , Ventricular Pressure/drug effects , Ventricular Pressure/physiology
20.
Immunopharmacol Immunotoxicol ; 28(3): 471-83, 2006.
Article in English | MEDLINE | ID: mdl-16997795

ABSTRACT

The rapidly developing resistance of many infectious pathogenic organisms to modern drugs has spurred scientists to search for new sources of antibacterial compounds. One potential candidate, bDLE (dialysis at 10 to 12 kDa cut-off) and its fractions ("S" and "L" by 3.5 kDa cut-off and I, II, III, and IV by molecular exclusion chromatography), was evaluated for antibacterial activity against pathogenic bacterial strains (Staphylococcus aureus, Streptococcus pyogenes, Lysteria monocytogenes, Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhi) using standard antimicrobial assays. A minimum inhibitory concentration (MIC) of bDLE and its fractions was determined by agar and broth dilutions methods. Only bDLE and its "S" fraction had an effect upon all bacteria evaluated (MIC ranging from 0.29 to 0.62 U/ml), and the bactericidal and bacteriostatic effects (evaluated by MTT assay) were bacterial species-dependent. These results showed a remarkable in vitro antibacterial property of bDLE against several pathogenic bacteria.


Subject(s)
Anti-Bacterial Agents/pharmacology , Transfer Factor/pharmacology , Animals , Anti-Bacterial Agents/chemistry , Cattle , Chromatography, Gel/methods , Colony Count, Microbial , Dialysis Solutions/analysis , Dialysis Solutions/chemistry , Dialysis Solutions/pharmacology , Dose-Response Relationship, Drug , Gram-Negative Bacteria/classification , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/growth & development , Gram-Positive Bacteria/classification , Gram-Positive Bacteria/drug effects , Gram-Positive Bacteria/growth & development , Humans , Microbial Sensitivity Tests , Molecular Weight , Transfer Factor/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...